Fifth Lane Capital »

Atrium Therapeutics shares owned by Fifth Lane Capital

Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by Fifth Lane Capital from 13F filings

Historical chart of Fifth Lane Capital investment in Atrium Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atrium Therapeutics held by Fifth Lane Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atrium Therapeutics by Fifth Lane Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $481k 36k 13.37

More positions owned by Fifth Lane Capital

Renatus Tactical Acquis Shs Cl A (RTAC)
Onestream Cl A
Cantor Equity Partners V Shs Cl A S (CEPV)
Hologic
Cantor Equity Partners Ii In Cl A Ord Shs
New Amer Acquisition I Corp Unit 99/99/9999 (NWAX.U)
Electronic Arts (EA)
Arcellx Common Stock (ACLX)
Futurecrest Acquisition Corp Cl A Ord Shs (FCRS)
Listed Fds Tr Roundhill Magnif (MAGS)
New Amer Acquisition I Corp Com Shs Cl A (NWAX)
Futurecrest Acquisition Corp Unit 99/99/9999 (FCRS.U)
UnitedHealth (UNH)
Abivax Sa Sponsored Ads (ABVX)
Core Scientific (CORZ)

View all positions for Fifth Lane Capital

Top funds holding Atrium Therapeutics

BlackRock
Susquehanna International
RA Capital Management
Vanguard Capital Management
TIG Advisors
Pentwater Capital Management
Sessa Capital IM
Goldman Sachs Group
Farallon Capital Management
Vanguard Portfolio Management
Geode Capital Management
683 Capital Management
Bellevue Group
State Street Corporation
Weiss Asset Management LP[1

View all funds holding Atrium Therapeutics